T 1556/14 (nab-Paclitaxel combinations/ABRAXIS) of 15.10.2020
- European Case Law Identifier
- ECLI:EP:BA:2020:T155614.20201015
- Date of decision
- 15 October 2020
- Case number
- T 1556/14
- Petition for review of
- -
- Application number
- 06735710.3
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- T 1556/14 nab-Paclitaxel combinations/ABRAXIS 2019-08-12
- Abstracts for this decision
- -
- Application title
- COMBINATIONS AND MODES OF ADMINISTRATION OF THERAPEUTIC AGENTS AND COMBINATION THERAPY
- Applicant name
- Abraxis BioScience, LLC
- Opponent name
- Generics [UK] Limited
MediGene Aktiengesellschaft - Board
- 3.3.01
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 104(1) (2007)European Patent Convention R 88(1) (2007)Rules of procedure of the Boards of Appeal Art 16 (2007)
- Keywords
- Apportionement of costs - admissibility (no)
- Catchword
- -
- Cited cases
- T 0765/89
Order
For these reasons it is decided that:
The request for apportionment of costs is inadmissible.